## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 8.6% in mid entry zone (4.0-10.0%), top 9% cross-sectional ranking. Short-term MRS_5 (2.2%) confirms momentum alignment. Strong momentum (+8.8% 5-day acceleration). Outperforming sector by 8.3%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($560.33)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Flower Knows Expands U.S. Retail Distribution By Entering Ulta Beauty**
- Source: PR Newswire | 20251209T130844 | Bullish | Relevance: 99%
- Flower Knows, a global cosmetics brand known for its vibrant and whimsical products, is significantly expanding its U.S. retail presence by debuting on Ulta.com as of December 7, 2025. This marks a major milestone in their international growth, making the U.S. their largest overseas market. The brand, which boasts millions of social media followers and celebrity endorsements, will offer 62 products across various categories and themed collections, ranging from $8-$45.

**2. Morgan Stanley Raises Ulta Beauty (ULTA) Price Target to $640**
- Source: GuruFocus | 20251208T185413 | Bullish | Relevance: 99%
-  Morgan Stanley has increased its price target for Ulta Beauty (ULTA) to $640, while maintaining an "Overweight" rating. This adjustment reflects a positive sentiment, aligning with similar price target raises from other analysts. The company, a leading beauty retailer, recently expanded its international presence and operates a successful partnership with Target.

**3. Ulta Beauty, Victoria’s Secret earnings add to strange economic snapshot**
- Source: CFO Brew | 20251208T190613 | Bullish | Relevance: 98%
- Despite a seemingly gloomy consumer sentiment, recent earnings reports from Ulta Beauty and Victoria’s Secret indicate strong consumer spending. Ulta Beauty raised its full-year sales outlook to $12.3 billion, while Victoria’s Secret saw a 9.2% year-over-year sales increase in Q3, its highest in over four years, even with fewer discounts. This suggests a complex economic picture where consumers are spending on both value and aspirational purchases across all income groups.

**4. Earnings, Guidance, and Inflows Send Ulta Beauty Skyward**
- Source: FXEmpire | 20251210T112803 | Bullish | Relevance: 98%
- Ulta Beauty (ULTA) shares have surged significantly since 2010 due to strong bullish outlier inflows, excellent third-quarter fiscal 2025 results, and positive annual guidance. The company's robust sales, earnings growth, and institutional buying support suggest continued upward momentum for the stock. Ulta Beauty has consistently been a top-rated stock at MoneyFlows, indicating strong buy pressure and growing fundamentals.

**5. B. Riley Raises Price Target on Ulta Beauty to $600 From $530, Keeps Neutral Rating**
- Source: marketscreener.com | 20251208T130246 | Somewhat-Bullish | Relevance: 97%
-  B. Riley has increased its price target for Ulta Beauty (ULTA) to $600 from $530, while maintaining a Neutral rating on the stock. This adjustment reflects analyst sentiment towards the beauty retailer, which specializes in cosmetics, perfumes, and salon services. The article also notes other recent analyst actions on Ulta Beauty, including several price target increases and upgrades.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 13, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |
| 2025-12-05 | DA Davidson | $650 | $625 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |
| 2025-12-05 | DA Davidson | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 13 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +8.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.42 elevated, pricing in significant growth expectations. Forward P/E 21.4x stretched relative to 10% growth. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (13 raises, avg +6%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.9B |
| Beta | 0.87 |
| 52W Range | $309.01 - $611.90 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.42 |
| Forward P/E | 21.4 |
| Current P/E | 23.6 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.2% to 8.6% (+8.8% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 90th percentile. MRS_5 at 2.2% confirms short-term momentum alignment. AM_20 at 11.2% shows strong absolute momentum above own 20MA. Outperforming sector by 8.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (9.06), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 8.59% (CS: 91) | Strong |
| RSI_14 | 69.7 | Neutral |
| MACD Histogram | 9.06 | Bullish |
| vs SMA20 | 1.112x | Above |
| vs SMA50 | 1.122x | Above |
| vs SMA200 | 1.282x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $600.65
- **Stop Loss:** $560.33 (6.7% risk)
- **Target:** $661.13 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 24
- **Position Value:** $14,415.60
- **Portfolio %:** 14.42%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.7% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*